Top in endocrinology: Obesity-promoting chemicals, menopausal hormone therapy
Click Here to Manage Email Alerts
New data presented at the European Society for Paediatric Endocrinology virtual meeting revealed that exposure to bisphenols, phthalates and perfluoroalkyl substances can increase the risk for obesity.
A report on the data was the top story in endocrinology last week.
Meanwhile, at the North American Menopause Society annual meeting, a presenter reviewed current research on menopausal hormone therapy and the cardiovascular, cognitive and cancer risks that should be considered when prescribing it. A summary of the presentation was another top story.
Read these and more news in endocrinology below:
Interventions needed to reduce exposure to obesity-promoting chemicals
Exposure to three common endocrine-disrupting chemicals can increase the risk for obesity, and their elimination may improve public health while also producing economic benefits, according to a speaker. Read more.
Consider benefits, risks when prescribing menopausal hormone therapy
Menopausal hormone therapy is safe and effective for many women experiencing bothersome symptoms like hot flashes, but treatment should be individualized for people with certain risk factors, according to a speaker. Read more.
Waiting to add milk, gluten, fruit to an infant’s diet may lower type 1 diabetes risk
Length of breastfeeding and timing of introducing certain foods to an infant’s diet — cow’s milk, gluten and fruit, in particular — may affect type 1 diabetes risk, according to results of a systematic review and meta-analysis. Read more.
Alendronate may reduce risk for type 2 diabetes
Alendronate, a drug commonly used to treat osteoporosis, may help protect against type 2 diabetes, according to a presenter at the European Association for the Study of Diabetes virtual meeting. Read more.
Weight loss may help adults achieve type 2 diabetes remission, irrespective of BMI
Adults with normal weight and type 2 diabetes may be able to achieve diabetes remission with weight loss, according to data presented at the European Association for the Study of Diabetes virtual meeting. Read more.